Skip navigation
Real-Time Quotes
Get Free Real-Time Quotes Direct From the NYSE and the NASDAQ!
Topic: Pharmaceuticals
 | Source: Reuters
Teva Pharmaceutical Industries said on Friday it would buy rival generic drugmaker Barr Pharmaceuticals for $7.46  billion to expand its leadership in the U.S. market and fortify its presence in Europe.
Thursday, 17 Jul 2008 | Source: Reuters
Second-quarter net profit at Novartis rose 17 percent to $2.27 billion, helped by the weak U.S. dollar and cost cutting efforts, beating forecasts and boosting its shares.
Monday, 14 Jul 2008 | Source: CNBC staff and wire reports
Genentech earnings fell short of analysts' expectations, but the company's shares rose slightly in extended trading as the firm lifted its profit forecast for the full year.
Tuesday, 8 Jul 2008 | Source: CNBC.com
New evidence of the power of the multi-billion dollar impotence drugs. A study just out in the peer-reviewed "British Medical Journal" says that the elderly are having sex more often, possibly due to the popular pills for erectile dysfunction.
Tuesday, 8 Jul 2008 | Source: The Associated Press
Drug developer Eli Lilly will buy SGX Pharmaceuticals for about $64 million in cash in an effort to expand its drug discovery efforts, the companies said Tuesday.
Wednesday, 2 Jul 2008 | Source: Reuters
Abbott Laboratories won U.S. approval to sell its drug-coated heart stent called Xience, the company said on Wednesday.
Wednesday, 25 Jun 2008 | Source: Reuters
U.S. regulators did not approve Merck & Co's application to expand marketing of its cervical cancer vaccine Gardasil to an older group of women within an expected review period, the drugmaker said.
Monday, 23 Jun 2008 | Source: Reuters
Walgreen posted a 2 percent increase in quarterly profit as sales were muted by a weak U.S. economy and slowing growth in prescription drug sales.
Wednesday, 21 May 2008 | Source: Reuters
Sanofi-Aventis' experimental drug aflibercept failed to meet its goal in a mid-stage ovarian cancer study but the French drug maker said on Wednesday it had shown some promising signs of effectiveness.
Monday, 19 May 2008 | Source: CNBC.com
A study claims "the time has come" for researchers to study ED drugs as preventive medicine for the heart.
Friday, 16 May 2008 | Source: Reuters
Genentech said on Thursday a trial of Avastin in colon cancer patients who have undergone surgery will be completed earlier than expected due to faster collection of data and a higher-than-planned number of patients with stage III cancer.
Tuesday, 6 May 2008 | Posted By: Mike Huckman | Source: CNBC.com
Too few influential doctors are telling the public if they have financial ties to the companies that make lifesaving drug-coated stents.
Tuesday, 29 Apr 2008 | Source: Reuters
Genentech and Biogen Idec said a key study of Rituxan did not meet its main goal of a response in patients with systemic lupus erythematosus, commonly called lupus.
Tuesday, 29 Apr 2008 | Source: Reuters
U.S. health regulators have rejected a new drug from Merck that was designed to raise the level of HDL, or "good" cholesterol, the company said, sending its shares plunging more than 10 percent.
Tuesday, 22 Apr 2008 | Source: Reuters
Australia's Sigma Pharmaceuticals and grocery wholesaler Metcash are in talks over a joint bid for assets being sold by Primary Health Care, both companies said on Tuesday.
Next
Posts |  TOPIC : Pharmaceuticals
arr's Chairman and CEO Bruce Downey told me Teva's CEO Schlomo Yanai made the first move... Read More
17 Jul 2008
I am out in the field today shooting a story in Boston for the upcoming big Alzheimer's meeting the end of this month... Read More
16 Jul 2008
More than ten years after Pfizer brought Viagra to market and brought erectile dysfunction out of the closet a new survey says a lot of men are still too embarrassed to talk about impotence with their doctor... Read More
15 Jul 2008
After a knee-jerk reaction to the downside after the closing bell yesterday to the surprising four-cent miss by Genentech, the shares are rallying big time in the early regular trading session... Read More
14 Jul 2008
Like so many people who knew Bobby Murcer or were fans of his, I was so sad to hear the news that he had passed away... Read More
VIDEO | TOPIC : Pharmaceuticals
A look at whether the pharma sector is ripe for consolidation, with CNBC's Mike Huckman
Generic drug giant Teva Pharmaceuticals bought rival Barr for $7 billion, and some analysts say this could spark a big w...
A look at the consolidation trends in the generic drug sector, with Shlomo Yanai, Teva Pharmaceuticals CEO
Inside the $7.46B deal, with Bruce Downey, Barr Pharmaceuticals chairman/CEO
Teva's $7B deal could be just the tip of the consolidation iceberg, with CNBC's Mike Huckman
HOME  |  NEWS  |  MARKETS  |  EARNINGS  |  INVESTING  |  VIDEO  |  CNBC TV  |  CNBC PLUS  |  CNBC HD+
About CNBC   |   Site Map   |   Privacy Policy   |   Terms of Service   |   Advertise   |   Help   |   Feedback   |   Video Reprints
  Data is a real-time snapshot   *Data is delayed at least 15 minutes

Global Business and Financial News, Stock Quotes, and Market Data and Analysis